Criteria Caixa’s Pfizer PFE Stock Holding History

Criteria Caixa’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,000	Closed	-$717K	–	53
2022 Q4	$717K	Buy	+14,000	New	+$671K	0.09%	36
2022 Q1	–	Sell	-40	Closed	-$2.36M	–	46
2021 Q4	$2.36M	Sell	40 -39,960	-100%	-$1.98M	0.29%	25
2021 Q3	$1.72M	Buy	+40,000	New	+$1.77M	0.24%	31
2020 Q4	–	Sell	-16,864	Closed	-$587K	–	46
2020 Q3	$587K	Buy	+16,864	New	+$591K	0.13%	33

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Criteria Caixa's PFE Position: Q4 2025 in Review

Criteria Caixa sold out of Pfizer (PFE) in Q4 2025, closing a stake of 1,805,855 shares — an estimated $46M sold.

Criteria Caixa first reported a position in PFE in Q4 2019 and held it in 24 quarters. The position peaked at $71.6M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Criteria Caixa reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Criteria Caixa sold 1,805,855 Pfizer shares in Q4 2025, an estimated $46M.
Criteria Caixa first reported a position in Pfizer in Q4 2019 and held it in 24 quarters.
Criteria Caixa's Pfizer position peaked at $71.6M in Q4 2021.
2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Criteria Caixa's 13F filing for Q4 2025, filed 17 Feb 2026.